Leadership Talks with Amaero (ASX: 3DA) Chairman & CEO Hank Holland

Company overview

• Name: Amaero (Amero) Limited (ASX: 3DA)
• Business: Advanced metal powder and powder‑metallurgy manufacturing focused on aerospace, defense and high‑temperature refractory alloys.
• Operations: US‑based facilities (Tennessee).

Strategic shift: redomiciliation and listing plan

• Announced intent to redomicile from Australia to the United States (incorporate in Delaware) while retaining the ASX listing.
• Target: pursue a US exchange listing in late CY2026 / early CY2027 after completing a PCAOB audit and obtaining shareholder and court approvals.
• Exchange mechanics (proposed): conversion of 40 ASX shares to 1 US share — stated to produce no change in relative economic interest.

Exchange conversion plan: 40 ASX shares → 1 US share (no net change in % ownership).

Core strategy

• First‑mover, industrial‑scale producer of spherical, high‑quality metal powders using IGA premium atomizers.
• Manufacture large, near‑net PM‑HIP (powder metallurgy – hot isostatic pressing) components.
• Target reshoring and rebuilding of the US defense industrial base with a dual commercial/government revenue mix (~50% government/defense overall; higher for refractory products).

Frameworks, processes and playbooks

Redomiciliation playbook

1. Board unanimous recommendation → shareholder vote.
2. Australian court process.
3. Engage PCAOB auditor (BDO retained).
4. Complete US exchange listing process (target late 2026 / early 2027).

First‑mover / ring‑fence strategy

• Invest upfront to secure capacity and defend commercial leads before competitors scale.
• Operate initially below peak utilisation (~50%) to absorb and attract reshoring demand.

Capacity‑driven go‑to‑market

• Build IGA atomizer and PM‑HIP capacity to qualify for and win long‑term supply agreements with aerospace, defense and industrial customers.

PM‑HIP production flow (operational process)

• Design canister for near‑net shape using advanced numerical modelling.
• Build and fill can with powder; outgas.
• Hot isostatic pressing (HIP) to produce large, near‑net parts with isotropic mechanical properties.

Demand‑driven equipment ordering

• Stage additional IGA purchases (e.g., 4th/5th machines for titanium) only after realized/contracted demand.

KPIs, metrics, targets and timelines

Capital and balance sheet

• Total raised over last ~4 years: A$150M (three institutional rounds and others).
• Capex program: A$72M announced ~3 years ago; planned completion by June (referenced year).
• Cash: ~A$52–53M reported at Dec 2025.

Production capacity

• Four commissioned IGA premium atomizers → ~850 tonnes/year spherical powder capacity (eventual design for six machines: five titanium, one dedicated refractory).
• IGA premium vs prior tech: ~2x yield throughput; ~50% less argon consumption; ~50% less bar feedstock requirement.

Revenue guidance

• FY26 guidance: A$18–20M revenue (reduced from prior guidance due to FY25 US government funding delays/government shutdown).

Contracts & order book

• 12 PM‑HIP contracts expected to recognize revenue before fiscal year end; one publicly announced (Boeing development project).
• Five contracts tied to the submarine industrial base.

Commercial targets / mix

• Expected revenue split: ~50% government/defense overall.
• Refractory alloys: could be ~90% defense.
• Titanium: largely commercial (≈10% defense).

Timeline highlights

• Third IGA commissioning expected in June (referenced year).
• Fourth IGA ordered in December (prior year).
• Redomiciliation and US listing process targeted for late CY2026 / early CY2027.

Concrete examples, case studies, partnerships and traction

Defense & government engagement

• US Navy convened meeting with shipbuilders and tier‑1 suppliers at Amero; subsequently issued an unusual letter highlighting forging ecosystem vulnerabilities, PM‑HIP readiness, and identifying Amero as a qualified supplier.
• Boeing: announced a development agreement addressing a key supply‑chain vulnerability (further announcements expected after program data).
• Air Force Research Lab and other defense contacts have expressed unsolicited interest in refractory powders for hypersonics/space.

Commercial partnerships

• Supply agreements / exclusives with laser‑powder‑bed‑fusion customers.
• Agreement with Titomic (ASX company) for large parts.

Technology capability examples

• One installed IGA premium atomizer is dedicated to refractory alloys (e.g., C103 niobium alloy, tungsten, zirconium). Amero claims unique ability to melt/atomize high‑temperature refractories.
• PM‑HIP used to make very large near‑net parts (5–10 tonnes) with isotropic (3‑D) mechanical properties that can be superior to forgings for some applications.

Historical proof points

• CEO Hank Holland previously sold LogicSource for 11x to a New York PE firm — cited as a personal evidence of thematic investment success.

Market context & strategic rationale

• Macro tailwinds: US government incentives, tariffs and policies to reshore manufacturing and rebuild the defense industrial base.
• Rising defense spending and geopolitical uncertainty increase demand for strategic alloys (hypersonics, missiles, space, nuclear).
• AI/data‑center growth cited indirectly as a driver for nuclear power‑related materials (e.g., zirconium).
• Supply chain problems targeted by Amero:
  • Heavy dependence on single foreign suppliers (example: Boeing historically dependent on a Russian firm for ~80% of forging capacity).
  • Long lead times: average forging lead time ~24 months; submarine part cycle ~28 months — PM‑HIP and local capacity can shorten lead times and derisk supply.
  • US shipbuilding scale gap: China produced ~350x US ship tonnage in 2024; US aims to increase submarine builds (goal ~5/year by 2028 from ~1.5 currently).

Differentiation and competitive advantages

• IGA premium atomizer technology:

  • Higher throughput and lower argon consumption vs prior generation.
  • Industrial scalability (target ~850 tpa with 4 machines).
  • Ability to atomize refractory metals (niobium, tungsten) that many competitors cannot.

• PM‑HIP near‑net capability:

  • Mature, proven for large complex parts; offers isotropic properties and forgings‑like or superior performance at scale.
  • Claimed leading numerical modelling capability for canister design (said to exceed national labs in capability).

• Financial and alignment advantages:

  • Founder/major investor alignment: Pegasus family office + Hank Holland hold >30% (no free options/performance rights); capital invested alongside public shareholders.
  • Significant institutional ownership (e.g., Fidelity International).

Risks, constraints and execution items

• Timing risk from government procurement cycles and appropriations (FY25 continuing resolution and government shutdown delayed awards/revenue by ~4 quarters).
• Execution risk scaling new industrial assets and qualifying mission‑critical materials/parts with defense primes and the US government.
• Market/commodity risk: refractory alloy inputs (e.g., hafnium) are volatile and rising (hafnium noted +60% since Aug 2025).
• Need for further demand validation before justifying incremental IGA purchases.

Actionable recommendations and operational tactics

• For shareholders / investors:

  • Consider a long‑term orientation; management emphasizes multi‑year value creation and a first‑mover moat rather than quarter‑by‑quarter optimization.
  • Redomiciliation could expand the US investor base and improve alignment with US government customers; ASX holders retain equivalent economic interest post‑conversion.
  • Current trading levels (below prior raise price A$0.40) were cited by management as a potential value opportunity relative to catalysts.

• For potential customers (OEMs / tier suppliers):

  • Engage early to secure capacity (Amero intends to run below peak utilisation to attract reshoring customers).
  • Use exclusive or long‑term supply agreements to secure priority as Amero scales.

• For operations:

  • Accelerate commissioning cadence (third IGA and PM‑HIP contract revenue recognition expected this fiscal year).
  • Improve unit economics (e.g., argon recycling plant ordered).
  • Continue demand‑driven equipment procurement to limit capex exposure while preserving a first‑mover installed base.

Notable metrics and data points

• A$150M raised over ~4 years.
• A$72M capex program (to be completed by June).
• A$52–53M cash at Dec 2025.
• FY26 revenue guidance: A$18–20M.
• 12 PM‑HIP contracts expected to recognize revenue this fiscal year; 1 announced (Boeing); 5 related to submarine industrial base.
• IGA installed‑base target: 4 machines → ~850 tpa; design for 6 machines (5 Ti / 1 refractory).
• Niobium C103 price: approx US$3,000/kg (~20x titanium).
• Hafnium price: +60% since Aug 2025.
• Redomiciliation exchange conversion plan: 40 ASX shares → 1 US share.

Presenters / sources

• Hank Holland — Chairman & CEO, Amero (Amaero / Amero Limited).
• Gia — interviewer/host (East Coast Research / Shares & Value).